These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 3237470)
1. [Possible involvement of immunologic factors in radiotherapy of mouse MM46 tumors (1). Modifying effects of radiation response using cyclophosphamide]. Kunugita N; Dohi S; Norimura T; Tsuchiya T Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Nov; 48(11):1459-66. PubMed ID: 3237470 [No Abstract] [Full Text] [Related]
2. The combined effects of x-rays and cell-borne immunity on cells of the C3H mouse tumour BP8, studied in vitro by a terminal dilution technique. Munro TR; Porteous DD Br J Radiol; 1972 Oct; 45(538):793. PubMed ID: 4672983 [No Abstract] [Full Text] [Related]
3. [Role of immunologic activity of host in radiotherapy]. Tsuchiya T Gan No Rinsho; 1983 Oct; 29(13):1499-505. PubMed ID: 6608014 [TBL] [Abstract][Full Text] [Related]
4. [Effect of immunomodifier on radiation-induced antitumor immunity following local irradiation to tumor--2. Mouse interferon-alpha/beta]. Mukae S; Norimura T; Tsuchiya T Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Oct; 48(10):1243-8. PubMed ID: 3222138 [No Abstract] [Full Text] [Related]
5. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors. Nitta K; Tanaka T; Takeuchi M Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657 [TBL] [Abstract][Full Text] [Related]
6. [Tumor immunity induced by local radiotherapy]. Yamashita T; Hayakawa Y; Hanajima K; Mochizuki S Gan No Rinsho; 1983 Oct; 29(13):1506-11. PubMed ID: 6422094 [TBL] [Abstract][Full Text] [Related]
7. [Effect of 4-nitroimidazole (iso-metronidazole) on the radiation-induced growth retardation and therapeutic quotient of transplanted tumors]. Magdon E Radiobiol Radiother (Berl); 1985; 26(3):351-8. PubMed ID: 4059521 [No Abstract] [Full Text] [Related]
8. [Experimental study of the antitumor effect of Z-100 in the treatment of MM46 tumor transplanted in C3H/He mice. 2. Effect of the combination therapy of radiation and long term administration of Z-100]. Ogawa Y; Inomata T; Yoshida S; Maeda T; Seguchi H Nihon Gan Chiryo Gakkai Shi; 1989 Jan; 24(1):51-6. PubMed ID: 2738440 [TBL] [Abstract][Full Text] [Related]
9. [Effect of different doses of cyclophosphamide on the immune response of mice with a methylcholanthrene-induced sarcoma]. Gordienko SP; Bergol'ts VM Vopr Onkol; 1973; 19(11):54-60. PubMed ID: 4785975 [No Abstract] [Full Text] [Related]
10. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors. Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824 [TBL] [Abstract][Full Text] [Related]
12. [Correction of anti-tumor immunity by beta-carotene during experimental chemotherapy of malignant neoplasms]. Ramanauskaĭte RIu; Abronina IF; Karaseva LI; Sergeev AV Biull Eksp Biol Med; 1994 Sep; 118(9):295-7. PubMed ID: 7819566 [No Abstract] [Full Text] [Related]
13. Combination therapy of murine tumors with a degraded D-manno-D-glucan (DMG) from Microellobosporia grisea, and cyclophosphamide. Nakajima H; Hashimoto S; Kita Y; Takashi T; Tsukada W; Kohno M; Ogawa H; Abe S; Mizuno D Jpn J Exp Med; 1983 Dec; 53(6):263-9. PubMed ID: 6240552 [TBL] [Abstract][Full Text] [Related]
14. [Anti-tumor activities of direct current (DC) therapy combined with fractionated radiation or chemotherapy]. Nakayama T; Ito H; Hashimoto S Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Oct; 48(10):1269-75. PubMed ID: 3265497 [No Abstract] [Full Text] [Related]
15. Treatment of metastatic osteosarcoma by cyclophosphamide and radiotherapy. Schaeffer J; el-Mahdi AM; Constable WC Radiology; 1974 May; 111(2):467-9. PubMed ID: 4522475 [No Abstract] [Full Text] [Related]
16. [The experimental study on dose related tumor-cell destruction and mononuclear-cell-infiltration--enzymatical study on topical tumor tissue of C3H/He mice innoculated MM46-tumor (author's transl)]. Imanaka K; Kimura S; Imajo Y; Takashima H; Ogawa Y; Oshitani T; Gose K; Ichiyanagi A; Miyaji C; Itoh H Nihon Igaku Hoshasen Gakkai Zasshi; 1981 Jan; 41(1):71-4. PubMed ID: 7232113 [No Abstract] [Full Text] [Related]
17. [Experimental study on the effectiveness of BRM in radiation therapy--OK-432 and cyclophosphamide]. Norimura T; Kunugita N; Dohi S; Mukae S; Tsuchiya T Gan No Rinsho; 1988 Oct; 34(13):1811-5. PubMed ID: 3199515 [TBL] [Abstract][Full Text] [Related]
18. [Combined use of radiosensitizing and protective agents in experimental radiotherapy]. Magdon E; Schröder E; Iarmonenko SP; Vygodskaia AL; Vinskaia NP Med Radiol (Mosk); 1984 Dec; 29(12):29-32. PubMed ID: 6513748 [TBL] [Abstract][Full Text] [Related]
19. Evolution of cell-mediated immunity in mice bearing tumors produced by a mammary carcinoma cell line. Influence of tumor growth, surgical removal, and treatment with irradiated tumor cells. Le François D; Youn JK; Belehradek J; Barski G J Natl Cancer Inst; 1971 May; 46(5):981-7. PubMed ID: 5157849 [No Abstract] [Full Text] [Related]
20. [Immunological analysis of chemotherapeutic effects for the effective immunochemotherapy against cancer]. Yamada Y Hokkaido Igaku Zasshi; 1984 Nov; 59(6):721-7. PubMed ID: 6397415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]